ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	24/179	191/7206	3.67879755848e-11
ko04380	Osteoclast differentiation	17/179	134/7206	2.74256893895e-08
ko04630	Jak-STAT signaling pathway	12/179	132/7206	9.9423520808e-05
ko04650	Natural killer cell mediated cytotoxicity	10/179	97/7206	0.000134870928996
ko05230	Central carbon metabolism in cancer	9/179	81/7206	0.000164865990706
ko05162	Measles	11/179	120/7206	0.000180704052191
ko04666	Fc gamma R-mediated phagocytosis	11/179	122/7206	0.000209278097643
ko05167	Kaposi's sarcoma-associated herpesvirus infection	14/179	191/7206	0.000267536030752
ko04659	Th17 cell differentiation	10/179	106/7206	0.000281736966928
ko05166	HTLV-I infection	18/179	292/7206	0.000319427164132
ko04610	Complement and coagulation cascades	8/179	79/7206	0.000718442656961
ko05231	Choline metabolism in cancer	10/179	134/7206	0.00177380445024
ko04933	AGE-RAGE signaling pathway in diabetic complications	10/179	135/7206	0.00187532648985
ko04144	Endocytosis	18/179	342/7206	0.00215643323238
ko04014	Ras signaling pathway	16/179	279/7206	0.00227044465203
ko04664	Fc epsilon RI signaling pathway	7/179	77/7206	0.00288544520409
ko04668	TNF signaling pathway	9/179	120/7206	0.00288861102295
ko04072	Phospholipase D signaling pathway	12/179	197/7206	0.00356359802822
ko04062	Chemokine signaling pathway	12/179	201/7206	0.00419173456395
ko05212	Pancreatic cancer	7/179	83/7206	0.00439975412939
ko04662	B cell receptor signaling pathway	7/179	88/7206	0.00606688845595
ko05200	Pathways in cancer	22/179	492/7206	0.00634804926703
ko04931	Insulin resistance	9/179	137/7206	0.0069136927199
ko04068	FoxO signaling pathway	10/179	167/7206	0.00852417367512
ko04919	Thyroid hormone signaling pathway	9/179	143/7206	0.00906602126402
ko04658	Th1 and Th2 cell differentiation	7/179	96/7206	0.00965886005494
ko04015	Rap1 signaling pathway	14/179	278/7206	0.00993585477414
ko04910	Insulin signaling pathway	10/179	172/7206	0.0103834186478
ko05140	Leishmaniasis	6/179	75/7206	0.0105497926707
ko05418	Fluid shear stress and atherosclerosis	10/179	173/7206	0.010789748404
ko04066	HIF-1 signaling pathway	8/179	123/7206	0.011287761026
ko05321	Inflammatory bowel disease (IBD)	5/179	56/7206	0.0122825814426
ko04672	Intestinal immune network for IgA production	4/179	37/7206	0.0128311637011
ko05214	Glioma	6/179	79/7206	0.0134312363217
ko04960	Aldosterone-regulated sodium reabsorption	4/179	41/7206	0.0182276605068
ko05213	Endometrial cancer	5/179	62/7206	0.018483137971
ko05169	Epstein-Barr virus infection	11/179	206/7206	0.0185977202115
ko05218	Melanoma	6/179	85/7206	0.0187232318208
ko05220	Chronic myeloid leukemia	6/179	85/7206	0.0187232318208
ko04611	Platelet activation	9/179	163/7206	0.0199929600125
ko05215	Prostate cancer	7/179	111/7206	0.0202297049471
ko04917	Prolactin signaling pathway	6/179	87/7206	0.0207650196028
ko04710	Circadian rhythm	4/179	43/7206	0.0213824148683
ko04550	Signaling pathways regulating pluripotency of stem cells	9/179	165/7206	0.0214579818525
ko05202	Transcriptional misregulation in cancer	10/179	188/7206	0.0267397372684
ko04064	NF-kappa B signaling pathway	6/179	96/7206	0.0318183960892
ko05164	Influenza A	9/179	167/7206	0.0372557589151
ko05340	Primary immunodeficiency	3/179	30/7206	0.0374416643318
ko04620	Toll-like receptor signaling pathway	6/179	100/7206	0.0377671630767
ko04930	Type II diabetes mellitus	4/179	54/7206	0.0444928755374
ko05168	Herpes simplex infection	9/179	182/7206	0.0468458834649
ko01521	EGFR tyrosine kinase inhibitor resistance	6/179	106/7206	0.0479496837609
ko04360	Axon guidance	11/179	233/7206	0.0486789125238
ko00254	Aflatoxin biosynthesis	1/179	2/7206	0.0490671375523
ko00073	Cutin, suberine and wax biosynthesis	1/179	2/7206	0.0490671375523